Two Boston-area biotechs raise combined $152M in IPOs

Cambridge-based Spero Therapeutics Inc., an antibiotics developer created by Atlas Venture, and Newton-based Allena Pharmaceuticals Inc. will both start trading on the Nasdaq market today.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.